Ledger.Open graph →
SEC Form D · Amendment · filed February 12, 2020

Tempest Therapeutics, Inc

Offering
$100.2M
Sold
$83.2M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Michael W. Raab · Fremont, CADirectorThomas J. Woiwode · San Francisco, CADirectorThomas W. Dubensky, Jr · South San Francisco, CAExec · DirectorPetpiboon W. Prasit · South San Francisco, CADirectorStella W. Xu · Shanghai, IsraelDirectorRobert W. Weisskoff · Cambridge, MADirectorJulian D. Bott · Oklahoma City, OKDirectorBryan Greene · Syracuse, NYDirectorPaul W. Grayson · San Francisco, CADirectorKeting W. Chu · Wilmington, DEDirectorJames D. Bennett · Oklahoma City, OKDirectorIvan Markman · CULVER CITY, CADirectorThomas W. Dubensky, Jr · South San Francisco, CAExec · DirectorPaul W. Grayson · San Francisco, CADirectorPetpiboon W. Prasit · South San Francisco, CADirectorStella W. Xu · Shanghai, IsraelDirectorRobert W. Weisskoff · Cambridge, MADirectorKeting W. Chu · Wilmington, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗